Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
1.80
Ask:
2.00
Spread: 0.20 (11.111%)
Market Cap: £8.30m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Form 8.5 (EPT/RI)-Renalytix Plc

17 Jun 2024 10:08

Form 8.5 (EPT/RI)-Renalytix Plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRenalytix plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Renalytix plc
(d) Date dealing undertaken: 14th June 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid / received (pence)Lowest price per unit paid / received (pence)
Ordinary Shares Purchase 21,888 18.98 18.725

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

Date of disclosure:17th June 2024
Contact name:Abhishek Gawde
Telephone number:+91 9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
4th Nov 20245:42 pmRNSHolding(s) in Company
31st Oct 20243:10 pmRNSDirectorate Change
31st Oct 20242:10 pmRNSResult of General Meeting
11th Oct 20244:55 pmRNSPosting of Circular & Notice of GM
11th Oct 20247:02 amRNSDirector/PDMR Shareholding
11th Oct 20247:01 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSHolding(s) in Company
9th Oct 20244:40 pmRNSHolding(s) in Company
8th Oct 20241:55 pmRNSAdmission of Shares & Total Voting Rights
8th Oct 20247:00 amRNSCommencement of trading on OTCQB in the US
1st Oct 202412:02 pmRNSResult of Placing and Subscription
1st Oct 20247:00 amRNSAudited US GAAP financial results
30th Sep 20245:42 pmRNSPlacing and Subscription
30th Sep 20245:41 pmRNSRe. Results for the fiscal year ended 30 June '24
30th Aug 20247:00 amRNSChange of Adviser
30th Aug 20247:00 amRNSTotal Voting Rights
27th Aug 20249:30 amRNSNasdaq Grants Listing Extension
21st Aug 20247:00 amRNSAppointment of Joint Corporate Broker
20th Aug 20247:00 amRNSTermination of Formal Sale Process
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
14th Aug 20249:47 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
7th Aug 20249:09 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
6th Aug 20249:42 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
5th Aug 20249:36 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
2nd Aug 202410:21 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
1st Aug 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
31st Jul 20249:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
30th Jul 20249:46 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20247:57 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
16th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
16th Jul 20247:46 amGNWForm 8.5 (EPT/RI)-Renalytix plc
15th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Jul 20247:00 amRNSIssue of Shares and Rule 2.9 Announcement
12th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
12th Jul 20249:05 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
11th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
11th Jul 20247:00 amRNSSteno Diabetes Center (Copenhagen) Collaboration
10th Jul 20243:26 pmRNSHolding(s) in Company
10th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202410:01 amRNSForm 8.5 (EPT/RI) - Renalytix plc - Amendment
2nd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.